Christoph Kausch is a healthcare investor who leads MTIP AG, a Pan-European growth equity firm exclusively focused on the healthtech. See contact routes.
Christoph Kausch is a healthcare investor who leads MTIP AG, a Pan-European growth equity firm exclusively focused on the healthtech sector, backing digital health and digitally connected medical device companies from Seed to Later Stage. His distinctive thesis requires proven revenue and profitability rather than just promising technology, shifting the firm’s focus from medical devices in Fund I to healthcare software exclusively from Fund II onward. A notable portfolio company is Oviva, a digital diabetes management platform where MTIP led the Series B round and achieved a 15x increase in enterprise value. MTIP’s second fund, which Kausch manages, raised $250 million to support businesses at the intersection of growing health sectors.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Basel.
Investors like Christoph Kausch · Full investor directory · Investor access · Company funding database